Bicyclically substituted uracils and the use thereof

US10300062B2 · kind B2 · utility

Assignee

• Bayer Pharma Aktiengesellschaft · DE

Inventors

• Chantal Fürstner · Neheim, DE
• Jens Ackerstaff · Mülheim an der Ruhr, DE
• Alexander Straub · Wuppertal, DE
• Heinrich Meier · Wuppertal, DE
• Hanna Tinel · Wuppertal, DE
• Katja Zimmermann · Mülheim an der Ruhr, DE
• Adrian Tersteegen · Wuppertal, DE
• Dmitry Zubov · Remscheid, DE
• Raimund Kast · Wuppertal, DE
• Jens Schamberger · Neviges, DE
• Martina Schäfer · Berlin, DE
• Kirsten BÖRNGEN · Neunburg vorm Wald, DE

Key dates

• Filing date: Mar 5, 2018
• Grant date: May 28, 2019
• Expiry date: Mar 5, 2038

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D471/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present application relates to novel bicyclically substituted uracil derivatives, to processes for preparation thereof, to the use thereof alone or in combinations for treatment and/or prophylaxis of diseases, and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases.